NuGen Medical Devices Inc.
NGMD.V
TSX
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -79.66% | -70.70% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -79.66% | -70.70% | |||
| Cost of Revenue | -79.49% | -78.63% | |||
| Gross Profit | -80.00% | -58.16% | |||
| SG&A Expenses | -7.05% | 2.42% | |||
| Depreciation & Amortization | -85.13% | -16.59% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -18.28% | -3.80% | |||
| Operating Income | 17.03% | -0.92% | |||
| Income Before Tax | 39.82% | 68.37% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 39.80% | 68.67% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 39.80% | 68.67% | |||
| EBIT | 17.03% | -0.92% | |||
| EBITDA | 5.35% | -4.45% | |||
| EPS Basic | 39.22% | 68.90% | |||
| Normalized Basic EPS | 40.63% | 64.44% | |||
| EPS Diluted | 39.22% | 68.90% | |||
| Normalized Diluted EPS | 40.63% | 64.44% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||